Cargando…

Prognostic impact of lymph node parameters in distal cholangiocarcinoma after pancreaticoduodenectomy

BACKGROUND: Pancreaticoduodenectomy is the only definitively curative therapy for the long-term survival of distal cholangiocarcinoma patients. Lymph node metastasis is widely accepted as an important prognostic factor for distal cholangiocarcinoma. The latest American Joint Committee on Cancer (AJC...

Descripción completa

Detalles Bibliográficos
Autores principales: Lyu, Shaocheng, Li, Lixin, Zhao, Xin, Ren, Zhangyong, Cao, Di, He, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7545845/
https://www.ncbi.nlm.nih.gov/pubmed/33032609
http://dx.doi.org/10.1186/s12957-020-02040-1
_version_ 1783592115012370432
author Lyu, Shaocheng
Li, Lixin
Zhao, Xin
Ren, Zhangyong
Cao, Di
He, Qiang
author_facet Lyu, Shaocheng
Li, Lixin
Zhao, Xin
Ren, Zhangyong
Cao, Di
He, Qiang
author_sort Lyu, Shaocheng
collection PubMed
description BACKGROUND: Pancreaticoduodenectomy is the only definitively curative therapy for the long-term survival of distal cholangiocarcinoma patients. Lymph node metastasis is widely accepted as an important prognostic factor for distal cholangiocarcinoma. The latest American Joint Committee on Cancer (AJCC) TNM classification system for distal cholangiocarcinoma has divided the lymph node metastasis patients into N1 and N2 by lymph node metastasis number. However, some studies suggested that the lymph node metastasis ratio may be better than the lymph node metastasis number. Therefore, we develop a program to analyze the correlation between lymph node parameters (lymph node dissection number, lymph node metastasis number, and lymph node metastasis rate) and long-term prognosis. METHODS: We retrospectively reviewed 123 distal cholangiocarcinoma patients after pancreatoduodenectomy from January 2011 to December 2019. The patients were grouped according to lymph node metastases and tumor-free and overall survival rates which were investigated with the Kaplan-Meier analysis. The logistic regression models were used for multivariate analysis to determine the risk factors for lymph node metastases. And the X-tile program was used to calculate the cutoff values for the lymph node parameters that discriminated survival. RESULTS: The 1-year, 3-year, and 5-year overall survival rates of patients with distal cholangiocarcinoma after pancreatoduodenectomy were 75.2%, 37.1%, and 31.5%, respectively. And the 1-year, 3-year, and 5-year overall survival rates of patients without and with lymph node metastasis were 83.0%, 50.7%, and 42.5% and 63.5%, 19.0%, and 19.0% (p = 0.000), respectively. Logistic regression showed CA19-9 and portal vein system invasion as independent risk factors for lymph node metastases. The receiver operating characteristic curve showed the optimal cutoff value of CA19-9 to predict the lymph node metastases was 75.5 U/mL. Determined by the X-tile software, the optimal cutoff values of the lymph node dissection number were 24 (p = 0.021), the lymph node metastasis number were 1 and 7 (p = 0.504), and the lymph node metastasis rate were 0.13 (p = 0.002). CONCLUSION: Lymph node metastasis is an important factor affecting the long-term survival of distal cholangiocarcinoma patients.CA19-9 and portal vein system invasion are independent risk factors for lymph node metastasis. Besides, the lymph node dissection number and lymph node metastasis rate can predict the long-term survival better than lymph node metastasis number.
format Online
Article
Text
id pubmed-7545845
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-75458452020-10-13 Prognostic impact of lymph node parameters in distal cholangiocarcinoma after pancreaticoduodenectomy Lyu, Shaocheng Li, Lixin Zhao, Xin Ren, Zhangyong Cao, Di He, Qiang World J Surg Oncol Research BACKGROUND: Pancreaticoduodenectomy is the only definitively curative therapy for the long-term survival of distal cholangiocarcinoma patients. Lymph node metastasis is widely accepted as an important prognostic factor for distal cholangiocarcinoma. The latest American Joint Committee on Cancer (AJCC) TNM classification system for distal cholangiocarcinoma has divided the lymph node metastasis patients into N1 and N2 by lymph node metastasis number. However, some studies suggested that the lymph node metastasis ratio may be better than the lymph node metastasis number. Therefore, we develop a program to analyze the correlation between lymph node parameters (lymph node dissection number, lymph node metastasis number, and lymph node metastasis rate) and long-term prognosis. METHODS: We retrospectively reviewed 123 distal cholangiocarcinoma patients after pancreatoduodenectomy from January 2011 to December 2019. The patients were grouped according to lymph node metastases and tumor-free and overall survival rates which were investigated with the Kaplan-Meier analysis. The logistic regression models were used for multivariate analysis to determine the risk factors for lymph node metastases. And the X-tile program was used to calculate the cutoff values for the lymph node parameters that discriminated survival. RESULTS: The 1-year, 3-year, and 5-year overall survival rates of patients with distal cholangiocarcinoma after pancreatoduodenectomy were 75.2%, 37.1%, and 31.5%, respectively. And the 1-year, 3-year, and 5-year overall survival rates of patients without and with lymph node metastasis were 83.0%, 50.7%, and 42.5% and 63.5%, 19.0%, and 19.0% (p = 0.000), respectively. Logistic regression showed CA19-9 and portal vein system invasion as independent risk factors for lymph node metastases. The receiver operating characteristic curve showed the optimal cutoff value of CA19-9 to predict the lymph node metastases was 75.5 U/mL. Determined by the X-tile software, the optimal cutoff values of the lymph node dissection number were 24 (p = 0.021), the lymph node metastasis number were 1 and 7 (p = 0.504), and the lymph node metastasis rate were 0.13 (p = 0.002). CONCLUSION: Lymph node metastasis is an important factor affecting the long-term survival of distal cholangiocarcinoma patients.CA19-9 and portal vein system invasion are independent risk factors for lymph node metastasis. Besides, the lymph node dissection number and lymph node metastasis rate can predict the long-term survival better than lymph node metastasis number. BioMed Central 2020-10-08 /pmc/articles/PMC7545845/ /pubmed/33032609 http://dx.doi.org/10.1186/s12957-020-02040-1 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Lyu, Shaocheng
Li, Lixin
Zhao, Xin
Ren, Zhangyong
Cao, Di
He, Qiang
Prognostic impact of lymph node parameters in distal cholangiocarcinoma after pancreaticoduodenectomy
title Prognostic impact of lymph node parameters in distal cholangiocarcinoma after pancreaticoduodenectomy
title_full Prognostic impact of lymph node parameters in distal cholangiocarcinoma after pancreaticoduodenectomy
title_fullStr Prognostic impact of lymph node parameters in distal cholangiocarcinoma after pancreaticoduodenectomy
title_full_unstemmed Prognostic impact of lymph node parameters in distal cholangiocarcinoma after pancreaticoduodenectomy
title_short Prognostic impact of lymph node parameters in distal cholangiocarcinoma after pancreaticoduodenectomy
title_sort prognostic impact of lymph node parameters in distal cholangiocarcinoma after pancreaticoduodenectomy
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7545845/
https://www.ncbi.nlm.nih.gov/pubmed/33032609
http://dx.doi.org/10.1186/s12957-020-02040-1
work_keys_str_mv AT lyushaocheng prognosticimpactoflymphnodeparametersindistalcholangiocarcinomaafterpancreaticoduodenectomy
AT lilixin prognosticimpactoflymphnodeparametersindistalcholangiocarcinomaafterpancreaticoduodenectomy
AT zhaoxin prognosticimpactoflymphnodeparametersindistalcholangiocarcinomaafterpancreaticoduodenectomy
AT renzhangyong prognosticimpactoflymphnodeparametersindistalcholangiocarcinomaafterpancreaticoduodenectomy
AT caodi prognosticimpactoflymphnodeparametersindistalcholangiocarcinomaafterpancreaticoduodenectomy
AT heqiang prognosticimpactoflymphnodeparametersindistalcholangiocarcinomaafterpancreaticoduodenectomy